Introducing Two New Hormonal Health Features: Birth Control Support and Menopause Insights

Why It Matters

By linking hormonal context to real‑time biometrics, Oura gives women actionable health insights at scale, potentially boosting user engagement and addressing a long‑standing gap in digital women’s health solutions.

Key Takeaways

• Oura adds hormonal birth control tracking to Cycle Insights.
• Menopause Insights uses MIS questionnaire linked to biometric data.
• Features roll out globally on May 6 for Ring Gen3 and 4.
• U.S. members can connect with Twentyeight Health providers in-app.
• Expands Oura’s women’s health suite across all life stages.

Pulse Analysis

Oura’s latest software update introduces two hormone‑focused experiences—Hormonal Birth Control support within Cycle Insights and Menopause Insights—marking a strategic push into women‑centric health tech. By marrying continuous biometric streams from the Ring (HRV, sleep, temperature) with self‑reported hormonal data, the platform offers a level of personalization that traditional health apps lack. The rollout begins on May 6 for Ring Generation 3 and Ring 4 users worldwide, signaling Oura’s intent to become a comprehensive health companion rather than a simple sleep tracker.

The Hormonal Birth Control module lets users select their contraceptive method—pill, patch, IUD, implant or others—and instantly see how that choice influences metrics such as resting heart rate and temperature variability. Symptom logging and bleeding tracking feed a conversational AI advisor, helping members differentiate normal fluctuations from warning signs. In the United States, Oura has partnered with Twentyeight Health, enabling a seamless telehealth pathway where members can consult licensed providers, obtain prescriptions, and adjust their regimen without leaving the app. This integration blurs the line between data collection and clinical care.

Menopause Insights builds on Oura’s research‑backed Menopause Impact Scale, a 22‑question survey that quantifies symptom burden and correlates it with objective biometrics. Users receive on‑demand explanations that tie sleep disruption, heart‑rate variability shifts, or temperature changes to specific perimenopausal symptoms, offering actionable lifestyle recommendations. The feature completes Oura’s women’s health suite, which already includes Fertile Window and Pregnancy Insights, positioning the company as a rare end‑to‑end solution in a market where women’s health remains under‑served. Analysts see the move as a potential catalyst for higher subscription retention among female users.